BioSpace News Archive

Business

Datavant and Verge Genomics Forge Strategic Alliance to Accelerate Drug Development

Datavant and Verge Genomics today announced a strategic alliance to unlock the value of pharmaceutical datasets to accelerate drug discovery and development.

January 5, 2018
·
3 min read
RTI Surgical Outlines 2018 Guidance and Long-Term Goals

RTI Surgical, a global surgical implant company, today outlined its 2018 guidance and long-term financial goals.

January 5, 2018
·
3 min read
Genetown

Glytec Awarded Patent Allowance Supporting Connected Care Model for Insulin Management

Glytec has been awarded another U.S. patent allowance for systems and methods related to insulin management in the outpatient environment.

January 5, 2018
·
3 min read
Business

Longtime CEO at Bay Area’s OncoMed Steps Down

Board of Directors has initiated search to identify successor.

January 5, 2018
·
4 min read
Deals

Owens & Minor Announces Updates on Pending Acquisition of Halyard Health’s S&IP Business

As part of the integration plan for the S&IP business, Owens & Minor anticipates it will organize into two strategic business units (SBUs): Global Solutions and Global Products.

January 5, 2018
·
4 min read
Drug Development

KalVista Pharmaceuticals Commences Two Clinical Trials

Both trials commenced in December 2017, in line with KalVista’s previously stated 2017 objectives.

January 5, 2018
·
5 min read
Biotech Beach

InnerScope Hearing Technologies Retains Barwicki Investor Relations to Provide Global Investor Relations Program

Barwicki Investor Relations is run by Andrew Barwicki, a seasoned veteran with 24 years of marketing and investor relations experience.

January 5, 2018
·
4 min read
Drug Development

Xencor Announces 2018 Priorities and Expected Milestones

The Company’s expected clinical development and research milestones are outlined.

January 5, 2018
·
7 min read
Drug Development

Immix Approved to Begin Phase I/IIa Study of Flagship Candidate

Immix Biopharma is proud to announce it has received Human Research Ethics Committee (IRB) approval to begin a Phase 1/2a Open-Label, Dose-Escalation/Dose-Expansion Safety, Tolerability and Pharmacokinetic Study of IMX-110 in Participants with Advanced Solid Tumors.

January 5, 2018
·
3 min read
Business

Rebiotix and CoreBiome Collaborate on Evaluating Microbiomes of Patients Treated With Microbiota Restoration Therapy

Rebiotix, announced today its successful first phase of collaboration with CoreBiome to measure the ability of RBX2660 and RBX7455 to rehabilitate the human microbiome impacted by recurrent Clostridium difficile infection.

January 5, 2018
·
4 min read